Intestinal-type and pancreatobiliary-type adenocarcinomas: how does ampullary carcinoma differ from other periampullary malignancies?
about
COX-2 overexpression in resected pancreatic head adenocarcinomas correlates with favourable prognosis.Prognostic and treatment predictive significance of SATB1 and SATB2 expression in pancreatic and periampullary adenocarcinoma.Intestinal-type of differentiation predicts favourable overall survival: confirmatory clinicopathological analysis of 198 periampullary adenocarcinomas of pancreatic, biliary, ampullary and duodenal originCharacterization of various cell lines from different ampullary cancer subtypes and cancer associated fibroblast-mediated responses.Expression and Prognostic Significance of Human Epidermal Growth Factor Receptors 1, 2 and 3 in Periampullary Adenocarcinoma.Substaging Nodal Status in Ampullary Carcinomas has Significant Prognostic Value: Proposed Revised Staging Based on an Analysis of 313 Well-Characterized CasesImmunohistochemical Typing of Adenocarcinomas of the Pancreatobiliary System Improves Diagnosis and Prognostic StratificationPrognostic Value of the Metastatic Lymph Node Ratio in Patients With Resectable Carcinoma of Ampulla of VaterAmpullary Cancers Harbor ELF3 Tumor Suppressor Gene Mutations and Exhibit Frequent WNT Dysregulation.Updated therapeutic outcome for patients with periampullary and pancreatic cancer related to recent translational research.Cytological features of mixed adenoneuroendocrine carcinoma of the ampulla: two case reports with review of literature.Histological and Molecular Subclassification of Pancreatic and Nonpancreatic Periampullary Cancers: Implications for (Neo) Adjuvant Systemic Treatment.Exceptional Response to Nanoparticle Albumin-Bound Paclitaxel and Gemcitabine in a Patient with a Refractory Adenocarcinoma of the Ampulla of VaterInfluence of Preoperative Therapy on Short- and Long-Term Outcomes of Patients with Adenocarcinoma of the Ampulla of Vater.Molecular signatures of mRNAs and miRNAs as prognostic biomarkers in pancreatobiliary and intestinal types of periampullary adenocarcinomasAmpullary carcinoma is often of mixed or hybrid histologic type: an analysis of reproducibility and clinical relevance of classification as pancreatobiliary versus intestinal in 232 cases.Clinicopathologic and survival analysis of resected ampullary adenocarcinoma.Non-ampullary-duodenal carcinomas: clinicopathologic analysis of 47 cases and comparison with ampullary and pancreatic adenocarcinomas.Phenotypic characterization and clinical outcome in ampullary adenocarcinoma.Immunophenotyping of ampullary carcinomata allows for stratification of treatment specific subgroups.Development of a Prognostic Model That Predicts Survival After Pancreaticoduodenectomy for Ampullary Cancer.Treatment utilization and surgical outcome of ampullary and duodenal adenocarcinoma.Ampullary cancer of intestinal origin and duodenal cancer - A logical clinical and therapeutic subgroup in periampullary cancer.Cardiorespiratory fitness and muscle strength in pancreatic cancer patients.Racial and ethnic disparities in a national cohort of ampullary cancer patients.Prognostic Value of Preoperative Serum Carcinoembryonic Antigen and Carbohydrate Antigen 19-9 After Resection of Ampullary Cancer.Differentiation of pancreatobiliary-type from intestinal-type periampullary carcinomas using 3.0T MRI.Factors predicting survival and pathological subtype in patients with ampullary adenocarcinoma
P2860
Q34502422-5E4E1776-36C5-48BD-B23B-5448B304C98FQ34515112-C52785C8-1DBB-4802-8CFA-5D268AF3F8B4Q34992861-0523CB02-9B30-4927-BFC8-CBA6B859FCCAQ35948210-1F40B063-D58C-4535-B6BF-02A5BA63940EQ35987242-4327F5CF-37F7-4BBF-B557-4FCBC4A13FA8Q36073271-872769C7-5C9C-4631-8752-ADFE19F92CE6Q36187546-E9894AA4-4408-4DBC-A4A5-12EE8AAE44C6Q36207162-B9A4EB0C-5592-4B8F-8414-CC2FCC3C1688Q37170296-ED6BFCC0-4901-40F5-A628-A7B25ACBA99DQ37538915-6FE440DE-21FC-4E84-A2DF-7ACEB667A864Q38189766-747B8AB0-C7C3-4AA9-873F-64D94BA2898DQ38287286-576E25A1-2E00-4892-9DE0-3641CC221F03Q38344071-7E8D17A5-7055-47D6-9C2D-55392841E8A0Q38998202-E881A77F-FDFC-48B2-9B9A-03006BF7A941Q39061625-BAB6E3EB-91FE-4006-812E-253654B36DF5Q39430742-0BCB1C53-5AF5-46AA-900B-D2306D5D12F6Q39784390-700490E3-BEAC-4BD1-BDA1-0A7372C9E144Q40542503-AF3EC73A-836E-4E34-8AC4-FAA35E5766F0Q40774298-4CD81B65-DEC3-4A03-9928-402A06879740Q41187076-7A786095-0957-4B88-98A5-49646A07D57BQ42678842-A54088B1-E0D8-44CE-B78F-3F9D5B115A3BQ46917699-9F423F65-A887-469B-9CA8-F7A36DC16406Q47124313-F8F24DCC-7A9B-4AD6-9DA9-6F18C3AA5A4FQ47578772-BF2DF312-7128-4E59-94C0-36FD578CB4E6Q47883236-78F626DE-0A19-46AC-B537-3E628D9F1B5EQ50217905-202B4F2B-3132-4896-A6C9-1B6185D7C187Q53183526-08A94912-FD8D-474C-A142-79FEE6DEF088Q57150924-73FC463A-3F77-4070-989F-6618B5233829
P2860
Intestinal-type and pancreatobiliary-type adenocarcinomas: how does ampullary carcinoma differ from other periampullary malignancies?
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Intestinal-type and pancreatob ...... er periampullary malignancies?
@en
Intestinal-type and pancreatob ...... er periampullary malignancies?
@nl
type
label
Intestinal-type and pancreatob ...... er periampullary malignancies?
@en
Intestinal-type and pancreatob ...... er periampullary malignancies?
@nl
prefLabel
Intestinal-type and pancreatob ...... er periampullary malignancies?
@en
Intestinal-type and pancreatob ...... er periampullary malignancies?
@nl
P2093
P2860
P1476
Intestinal-type and pancreatob ...... er periampullary malignancies?
@en
P2093
Arne Westgaard
Ewa Pomianowska
Ole Petter F Clausen
P2860
P2888
P304
P356
10.1245/S10434-012-2603-0
P577
2012-09-07T00:00:00Z
P6179
1029849102